19 May 2020
Biospectator Interview : Minsoo Choi, CEO of NetTargets
NetTargets introduced the core platforms N-MAP and N-CAP at the Biopharma Tech concert on May 21st.
For more detailed information please refer to this Korean news article.
We are delighted to announce that NetTargets has been named the Most Innovative Drug Discovery Company in East Asia at the Global Health and Pharma Biotechnology Awards 2023.
NetTargets will deliver a presentation at BIO KOREA 2023, to be held on 10-12 May at COEX, SEOUL (Presentation Schedule: May 11, 2023, 10:40 AM (KST)). It will also participate in partnering meetings and exhibit at the booth (no. Q25) during the conference.